Antibody and T cell responses induced in chickens immunized with avian influenza virus N1 and NP DNA vaccine with chicken IL-15 and IL-18

Research in Veterinary Science

Volumn 95, Issue 3, 2013, Pages 1224-1234

  Lim, Kian Lam ^a,b   Jazayeri, Seyed Davoud ^a   Yeap, Swee Keong ^a   Mohamed Alitheen, Noorjahan Banu ^a   Bejo, Mohd Hair ^a   Ideris, Aini ^a   Omar, Abdul Rahman ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

Author keywords

Avian influenza virus; CD4+ T cells; CD8+ T cells; DNA vaccine; IL 15; IL 18; N1; NP

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; INTERLEUKIN 15; INTERLEUKIN 18; NUCLEOPROTEIN; PLASMID DNA; PROTEIN; RECOMBINANT DNA; VIRUS SIALIDASE;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHICKEN; CONTROLLED STUDY; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE FUNCTION; MOLECULAR CLONING; N1 GENE; NONHUMAN; NP GENE; VIRUS GENE;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS;

AVIAN INFLUENZA VIRUS; CD4+ T CELLS; CD8+ T CELLS; DNA VACCINE; IL-15; IL-18; N1; NP;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CHICKENS; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INTERLEUKIN-15; INTERLEUKIN-18; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VACCINES, DNA; VERO CELLS;

EID: 84888014106     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2013.07.013     Document Type: Article

References (37)

1. Beck E., Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. Journal of Virology 1987, 61:1621-1629.
2. Chen H.-Y., Zhao L., Wei Z.-Y., Cui B.-A., Wang Z.-Y., Li X.-S., Xia P.-A., Liu J.-P. Enhancement of the immunogenicity of an infectious laryngotracheitis virus DNA vaccine by a bicistronic plasmid encoding glycoprotein B and interleukin-18. Antiviral Research 2010, 87:235-241.
3. Chen Q., Kuang H., Wang H., Fang F., Yang Z., Zhang Z., Zhang X., Chen Z. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 2009, 38:30-38.
4. Epstein S.L., Kong W.-P., Misplon J.A., Lo C.-Y., Tumpey T.M., Xu L., Nabel G.J. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 2005, 23:5404-5410.
5. 3 release of CD4+ T cells in the chicken: conservation of a Th1-like system in a nonmammalian species. The Journal of Immunology 2003, 171:1809-1815.
6. Guo Z., Wang H., Yang T., Wang X., Lu D., Li Y., Zhang Y. Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus. Journal of Virological Methods 2010, 167:84-89.
7. Huntington N.D., Legrand N., Alves N.L., Jaron B., Weijer K., Plet A., Corcuff E., Mortier E., Jacques Y., Spits H. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. Journal of Experimental Medicine 2009, 206:25-34.
8. Hyodo Y., Matsui K., Hayashi N., Tsutsui H., Kashiwamura S.-i., Yamauchi H., Hiroishi K., Takeda K., Tagawa Y.-i., Iwakura Y. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. The Journal of Immunology 1999, 162:1662-1668.
9. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., Li Y., Wang X., Ge J., Bu Z., Chen H. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Research 2007, 75:234-241.
10. Johansson B.E., Brett I.C. Recombinant influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines. Human Vaccines 2008, 4:420-424.
11. Johansson B.E., Bucher D.J., Kilbourne E.D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. Journal of Virology 1989, 63:1239-1246.
12. Johansson B.E., Grajower B., Kilbourne E.D. Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine 1993, 11:1037-1039.
13. Johansson B.E., Matthews J.T., Kilbourne E.D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 1998, 16:1009-1015.
14. Kalthoff D., Giritch A., Geisler K., Bettmann U., Klimyuk V., Hehnen H.-R., Gleba Y., Beer M. Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection. Journal of Virology 2008, 84:12002-12010.
15. Kilbourne E.D., Laver W.G., Schulman J.L., Webster R.G. Antiviral activity of antiserum specific for an influenza virus neuraminidase. Journal of Virology 1968, 2:281-288.
16. Koch G., Voermans J.J.M., van der Goot J.A. Validation of an N1 antibody competitive ELISA. Proceedings of the Joint Twelfth Annual Meetings of the National Newcastle Disease and Avian Influenza Laboratories of Countries of the European Union, Brussels, Belgium 2008, 56-57. J.A. Dennis (Ed.).
17. Kodihalli S., Kobasa D.L., Webster R.G. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 2000, 18:2592-2599.
18. Lauwerys B.R., Garot N., Renauld J.-C., Houssiau F.d.r.A. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. The Journal of Immunology 2000, 165:1847-1853.
19. Leitner W.W., Ying H., Restifo N.P. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 1999, 18:765-777.
20. Lim K.L., Jazayeri S.D., Yeap S.K., Alitheen N.B., Bejo M.H., Ideris A., Omar A.R. Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses. BMC Veterinary Research 2012, 8:132.
21. Liu M., Wood J.M., Ellis T., Krauss S., Seiler P., Johnson C., Hoffmann E., Humberd J., Hulse D., Zhang Y., Webster R.G., Perez D.R. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 2003, 314:580-590.
22. Liu M.A., Ulmer J.B. Human clinical trials of plasmid DNA vaccines. Advances in Genetics 2005, 55:25-40.
23. Luo M., Tao P., Li J., Zhou S., Guo D., Pan Z. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Journal of Virological Methods 2008, 154:121-127.
24. Marshall D.J., Rudnick K.A., McCarthy S.G., Mateo L.R.S., Harris M.C., McCauley C., Snyder L.A. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 2006, 24:244-253.
25. McNulty M.S., Allan G.M., Adair B.M. Efficacy of avian influenza neuraminidase-specific vaccines in chickens. Avian Pathology 1986, 15:107-115.
26. Nayak B., Kumar S., DiNapoli J.M., Paldurai A., Perez D.R., Collins P.L., Samal S.K. Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. Journal of Virology 2010, 84:2408-2420.
27. Palese P., Tobita K., Ueda M., Compans R.W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61:397.
28. Pertmer T.M., Oran A.E., Moser J.M., Madorin C.A., Robinson H.L. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein. Journal of Virology 2000, 74:7787-7793.
29. Purton J.F., Tan J.T., Rubinstein M.P., Kim D.M., Sprent J., Surh C.D. Antiviral CD4+ memory T cells are IL-15 dependent. Journal of Experimental Medicine 2007, 204:951-961.
30. Roy S., Kobinger G.P., Lin J., Figueredo J., Calcedo R., Kobasa D., Wilson J.M. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 2007, 25:6845-6851.
31. Saha S., Yoshida S., Ohba K., Matsui K., Matsuda T., Takeshita F., Umeda K., Tamura Y., Okuda K., Klinman D. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus. Virology 2006, 354:48-57.
32. Sasaki S., Takeshita F., Oikawa T., Kojima Y., Xin K.-Q., Okuda K., Ishii N. Improvement of DNA vaccine immunogenicity by a dual antigen expression system. Biochemical and Biophysical Research Communications 2004, 315:38-43.
33. Suarez D.L., Schultz-Cherry S. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Diseases 2000, 44:861-868.
34. Sylte M.J., Hubby B., Suarez D.L. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 2007, 25:3763-3772.
35. Tamura S.-i., Tanimoto T., Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Japanese Journal of Infectious Diseases 2005, 58:195.
36. Ulmer J.B., Fu T.-M., Deck R.R., Friedman A., Guan L., DeWitt C., Liu X., Wang S., Liu M.A., Donnelly J.J. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. Journal of Virology 1998, 72:5648-5653.
37. Wu R., Hu S., Xiao Y., Li Z., Shi D., Bi D. Development of indirect enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection and quantification of antibodies against avian influenza virus. Veterinary Research Communications 2007, 31:631-641.